Delivery Order SPE2DB22D2007-SPE2DB24FH8UX
Award Date 1/19/24
Potential Completion Date 2/9/24
Potential Value $14K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $106,869.32 contract is for the supply of REVLIMID 5 MG CAPSULE 100S, a pharmaceutical product, with a completion date of May 25, 2022. AmerisourceBergen Drug Corp, a for-profit organization, has received numerous federal contracts to provide pharmaceuticals, medical supplies, and related distribution...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4557530338 - REVLIMID 5 MG CAPSULE 100S. The $160,303.95 firm fixed price delivery order contract has a completion date of July 5, 2022 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REVLIMID 20 MG CAPSULE 100S. The award, valued at $89,155.06, has an ultimate completion date of October 8, 2024. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a comprehensive range of medical commodities. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REVLIMID 10 MG CAPSULE 100S. The order has a potential value of $158,419.32 and a completion date of February 5, 2024. No set-aside was used for this award. AmerisourceBergen Drug Corp is a prime contractor that provides pharmaceutical products and distribution services to support DLA Troop Support Medical facilities. The company...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $27,859.78, is for the delivery of REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product, with a performance period through April 3, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $56,490.52 firm-fixed-price contract is for the delivery of Revlimid 10 mg capsules and has an ultimate completion date of January 22, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 100 capsules of the pharmaceutical Revlimid 10 mg, with a potential value of $213,074.21. The delivery order is part of a larger indefinite delivery contract with DLA Troop Support Medical for Amerisourcebergen to provide pharmaceuticals and medical supplies to support military treatment...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at approximately $33.6K by the Defense Logistics Agency (DLA) on January 29, 2026, for the supply of Revlimid 10 mg capsules (quantity: 28-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by February 20, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's existing Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit subsidiary of AmerisourceBergen Corporation that provides pharmaceutical products and medical supplies. The contract is a delivery order valued at $105,612.88 for the supply of 4,564,123,531 units of the prescription drug REVLIMID 10 MG CAPSULE 100S. The contract has a firm fixed price pricing type and an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $12,993.03 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (quantity: 28 units). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 12, 2025. The pharmaceutical supply will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...